Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Estrigenix Therapeutics closed a $2M Series Seed financing round led by Talents Fund I to advance their ERβ platform for women's health and neurodegenerative diseases.
Amount Raised
$2 Million
Round Type
Seed
MilwaukeeBiotechnologyHealth CareTherapeuticsInvestors
Description
Estrigenix Therapeutics has successfully closed the first tranche of its $2 million Series Seed round. The financing aims to advance their ERβ platform, which focuses on women's health and neurodegenerative diseases. Talents Fund I led this funding round. This investment will support further development of their innovative technologies.
Related People
Funding Insights
Based on industry dataWatching Estrigenix Therapeutics? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan